The court held that those patents did not satisfy the requirements for listing in the Orange Book, finding that the patents did not claim the drug or drug product for which the associated New Drug ...

MedPage Today asked policy experts and physicians whether a Trump administration would continue down that same path. "With respect to competition, it has actually been really heartening to see the ...

The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

The drug and device industries have a lot hinging on the results of the Nov. 5 U.S. presidential and congressional elections.

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

Tremfya (guselkumab) is a prescription drug that’s used to treat certain autoimmune conditions, including plaque psoriasis. Tremfya can cause side effects that range from mild to serious.

It is generally well appreciated that the pharmaceutical industry has entered a period of revenue underperformance. However, the severity of this underperformance, even when measured against ...

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...

On Monday, October 7, 2024, the U.S. Supreme Court (“SCOTUS”) denied United Therapeutics Corporation (“UTC”) petition for certiorari clearing the way for Liquidia Corporation (“Liquidia ...

In most cases, these side effects should be temporary. And some may be easily managed. But for symptoms that are ongoing or bothersome, talk with your doctor or pharmacist. And do not stop taking ...